Advertisement

Topics

Cadence Pharmaceuticals Company Profile

07:15 EDT 23rd September 2017 | BioPortfolio

Cadence Pharmaceuticals, Inc. (formerly Strata Pharmaceuticals, Inc.) is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. Since our inception in 2004, we have in-licensed rights to two Phase III product candidates, both of which have been studied in prior Phase III clinical trials conducted by our licensors. We have in-licensed the exclusive U.S. and Canadian rights to IV APAP (acetaminophen for injection), which is currently marketed in Europe for the treatment of acute pain and fever by Bristol-Myers Squibb Company. We have also in-licensed the exclusive North American and European rights to Omigard™, a topical antimicrobial, for the prevention and treatment of device-related, surgical wound-related and burn-related infections. We believe that the hospital setting is a concentrated, underserved market for pharmaceuticals and anticipate building our own, hospital-focused sales force as our product candidates approach potential U.S. Food and Drug Administration, or FDA, approval. According to data from IMS Health Inc., or IMS, an independent marketing research firm, approximately $28 billion was spent on promotional activities by the pharmaceutical industry in 2005. Of this amount, IMS estimates that only $1 billion was directed towards hospital-based physicians and directors of pharmacies. In contrast, U.S. hospitals and clinics accounted for approximately $54 billion or 21% of U.S. pharmaceutical sales in 2005, according to IMS. We believe the relative lack of promotional efforts directed toward the highly concentrated hospital marketplace makes it an underserved and compelling opportunity, especially for a biopharmaceutical company commercializing its products directly through its own dedicated sales force.

Location

12481 High Bluff Drive, Suite 200
San Diego
92130
United States of America

Contact

Phone: 858-436-1400
Fax: 858-436-1401
Email: info@cadencepharm.com


News Articles [1257 Associated News Articles listed on BioPortfolio]

Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013

SAN DIEGO, July 2, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principal...

Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Leerink Swann 2012 Global Healthcare Conference on February 15, 2012

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products prin...

Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013

SAN DIEGO, Aug. 6, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product...

Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors

SAN DIEGO, Aug. 15, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary p...

Automatic Heart Analyzing CADence System Cleared by FDA

AUM Cardiovascular, a company out of Northfield, Minnesota, won FDA clearance for its CADence system, which is a novel combination of a stethoscope and ECG... Read More →

Cadence Pharmaceuticals Announces Proposed Public Offering of Common Stock

SAN DIEGO, Nov. 14, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced its intention to offer and sell $75 million worth of shares of its common stock in an underwritten...

One of the most hated drug companies on Wall Street is facing...

Senator Claire McCaskill has sent a letter to Mallinckrodt Pharmaceuticals, asking the company for details about the pricing of its pain medication, Ofirmev. Ofirmev can be used as a safer alternative...

Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock

SAN DIEGO, Nov. 15, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has priced an underwritten public offering of 19,000,000 shares of its common stock at a p...

Drugs and Medications [271 Associated Drugs and Medications listed on BioPortfolio]

Ofirmev [Cadence Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use OFIRMEV™ safely and effectively. See full prescribing information for OFIRMEV. OFIRMEV (acetaminophen) Injection Initial U.S. Approv...

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

PubMed Articles [187 Associated PubMed Articles listed on BioPortfolio]

Impact of Walking Cadence Prescription to Reach the Global Physical Activity Recommendations in Older Adults.

Walking cadence is a new monitoring strategy used to increase bouts of time at moderate intensity.

The choice of freely preferred cadence by trained nonprofessional cyclists may not be characterized by mechanical efficiency.

Most cycling studies involve professional cyclists. Because training may affect riding style, it is of interest to determine the physiological basis for the personal choice of cycling cadence in nonpr...

Different cadences and resistances in sub-maximal synchronous handcycling in able-bodied men: Effects on efficiency and force application.

With the introduction of an add-on handcycle, a crank system that can be placed in front of a wheelchair, handcycling was made widely available for daily life. With it, people go into town more easily...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Clinical Trials [214 Associated Clinical Trials listed on BioPortfolio]

Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)

The purpose of this non-significant risk study is to collect performance information regarding the use of the CADence system under normal conditions of use. This is a prospective, multi-c...

Cadence and Intensity Across the Adult Lifespan

The purpose of this study is to determine and link cadence (the number of steps taken in a minute) to the intensity of physical activity (e.g. low-, moderate- and vigorous-intensity) in ad...

Step Rate in Recreational Runners

This will be a pilot study to determine if a 6 week home training program can increase preferred step rate (cadence) in recreational runners. Increase in step rate has been correlated with...

CADence Performance as a Rule-Out Modality in Long Beach Veterans Administration Heart Catheterization Lab Patients

The purpose of the study is to evaluate the safety and performance of the CADence device by comparing it to the results obtained from standard coronary angiography. The CADence device coll...

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. ...

Companies [1285 Associated Companies listed on BioPortfolio]

Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 201...

Cadence Senior Living

Cadence is an owner, operator and developer of senior living communities based in Scottsdale, Ariz. Cadence principals have more than 30 years of senior housing development and ma...

Image Solutions, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing as well as on developing and commercializing proprietary product candidates principally for use in h...

Cadence, Inc.

Cadence is a premier metals manufacturing company focused on new medical technologies, such as minimally invasive devices. Headquartered in the Green Hills Technology Center in Staunton, Virginia, Ca...

Mallinckrodt plc and Cadence Pharmaceuticals, Inc.

More Information about "Cadence Pharmaceuticals" on BioPortfolio

We have published hundreds of Cadence Pharmaceuticals news stories on BioPortfolio along with dozens of Cadence Pharmaceuticals Clinical Trials and PubMed Articles about Cadence Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cadence Pharmaceuticals Companies in our database. You can also find out about relevant Cadence Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record